Summit Therapeutics Inc. ( NASDAQ: SMMT) today announced that ivonescimab data will be featured in numerous presentations at the European Society for Medical Oncology 2026 Congress (ESMO 2026), taking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results